[1] NAKHLEH A,SHEHADEH N.Hypoglycemia in diabetes:an update on pathophysiology,treatment,and prevention[J].World J Diabetes,2021，12(12):2036-2049.
[2] DOUILLARD C,JANNIN A,VANTYGHEM M C.Rare causes of hypoglycemia in adults[J].Ann Endocrinol(Paris),2020，81(2-3):110-117.
[3] GUEMES M,RAHMAN S A,HUSSAIN K.What is a normal blood glucose?[J].Arch Dis Child,2016，101(6):569-574.
[4] D'SOUZA A M,NEUMANN U H,GlAVAS M M,et al.The glucoregulatory actions of leptin[J].Mol Metab,2017，6(9):1052-1065.
[5] RENO C M,DING Y,SHERWIN R.Leptin acts in the brain to influence hypoglycemic counterregulation:disparate effects of acute and recurrent hypoglycemia on glucagon release[J].Am J Physiol Endocrinol Metab,2015，309(12):E960-E967.
[6] HACKL M T,FURNSINN C,SCHUH C M,et al.Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis[J].Nat Commun,2019，10(1):2717.
[7] MORRISON C D,DUVALL M A,HILL C M,et al.Leptin receptor signaling is required for intact hypoglycemic counterregulation:a study in male Zucker rats[J].J Diabetes Complications,2021，35(10):107994.
[8] YAN Y,NIU Z,SUN C,et al.Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism[J].Nat Commun,2022，13(1):6408.
[9] KATZ L S,ARGMANN C,LAMBERTINI L,et al.T3 and glucose increase expression of phosphoenolpyruvate carboxykinase(PCK1) leading to increased beta-cell proliferation[J].Mol Metab,2022，66:101646.
[10] PARK E A,SONG S,VINSON C,et al.Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription[J].J Biol Chem,1999，274(1):211-217.
[11] NISHI M.Diabetes mellitus and thyroid diseases[J].Diabetol Int,2018，9(2):108-112.
[12] ALLARD C,MORFORD J J,XU B,et al.Loss of nuclear and membrane estrogen receptor-alpha differentially impairs insulin secretion and action in male and female mice[J].Diabetes,2019，68(3):490-501.
[13] BIAN C,BAI B,GAO Q,et al.17beta-estradiol regulates glucose metabolism and insulin secretion in rat islet beta cells through GPER and Akt/mTOR/GLUT2 Pathway[J].Front Endocrinol(Lausanne),2019，10:531.
[14] CAMPOREZ J P,LYU K,GOLDBERG E L,et al.Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance[J].J Physiol,2019，597(15):3885-3903.
[15] IWASE M,KOMORITA Y,FUJII H,et al.Incidence of severe hypoglycemia and its association with serum adiponectin in Japanese patients with type 1 and insulin-treated type 2 diabetes:the Fukuoka diabetes registry[J].J Diabetes Investig,2020，11(5):1258-1264.
[16] DING Y,ZHANG D,WANG B,et al.APPL1-mediated activation of STAT3 contributes to inhibitory effect of adiponectin on hepatic gluconeogenesis[J].Mol Cell Endocrinol,2016，433:12-19.
[17] ONODERA T,WANG M Y,RUTKOWSKI J M,et al.Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization[J].Nat Commun,2023，14(1):6531.
[18] NAUCK M A,MEIER J J.Incretin hormones:their role in health and disease[J].Diabetes Obes Metab,2018，20(Suppl 1):5-21.
[19] DELEON D D,LI C,DELSON M I,et al.Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/-mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion[J].J Biol Chem,2008，283(38):25786-25793.
[20] FOURTNER S H,STANLEY C A,KELLY A.Protein-sensitive hypoglycemia without leucine sensitivity in hyperinsulinism caused by K(ATP) channel mutations[J].J Pediatr,2006，149(1):47-52.
[21] CALABRIA A C,CHARLES L,GIVLER S,et al.Postprandial hypoglycemia in children after gastric surgery:clinical characterization and pathophysiology[J].Horm Res Paediatr,2016，85(2):140-146.
[22] TAN M,LAMENDOLA C,LUONG R,et al.Safety,efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide(exendin 9-39) for treatment of post-bariatric hypoglycaemia[J].Diabetes Obes Metab,2020，22(8):1406-1416.
[23] El K,GRAY S M,CAPOZZI M E,et al.GIP mediates the incretin effect and glucose tolerance by dual actions on alpha cells and beta cells[J].Sci Adv,2021，7(11):1948.
[24] MULLER T D,FINAN B,BLOOM S R,et al.Glucagon-like peptide 1(GLP-1)[J].Mol Metab,2019，30:72-130.
[25] DURING M J,CAO L,ZUZGA D S,et al.Glucagon-like peptide-1 receptor is involved in learning and neuroprotection[J].Nat Med,2003，9(9):1173-1179.
[26] KRIEGER J P.Intestinal glucagon-like peptide-1 effects on food intake:physiological relevance and emerging mechanisms[J].Peptides,2020，131:170342.
[27] FLAK J N,GOFORTH P B,DELLORCO J,et al.Ventromedial hypothalamic nucleus neuronal subset regulates blood glucose independently of insulin[J].J Clin Invest,2020，130(6):2943-2952.
[28] KIM H T,DESOUZA A H,UMHOEFER H,et al.Cholecystokinin attenuates beta-cell apoptosis in both mouse and human islets[J].Transl Res,2022，243:1-13.
[29] PHILLIPS L K,PRINS J B.Update on incretin hormones[J].Ann N Y Acad Sci,2011，1243:E55-E74.
[30] DRUMMOND J B,SOARES B S,VIEIRA E L M,et al.Interleukin-6 response to insulin-induced hypoglycemia is associated with hypothalamic-pituitary-adrenal axis activation[J].J Neuroimmunol,2020，350:577446.
[31] WU R,LIU X,YIN J,et al.IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice[J].Metabolism,2018，83:18-24.
[32] LANGLEHRSKOV L,LYNGBAEK M P,SOEDERLUND L,et al.Interleukin-6 delays gastric emptying in humans with direct effects on glycemic control[J].Cell Metab,2018，27(6):1201-1211. |
